Effects of probiotic Bifidobacterium bifidum G9‐1 on the gastrointestinal symptoms of patients with type 2 diabetes mellitus treated with metformin: An open‐label, single‐arm, exploratory research trial

AIMS/INTRODUCTION: Metformin is associated with the risk of gastrointestinal complications, and probiotic Bifidobacterium bifidum G9‐1 (BBG9‐1) can improve the symptoms of diarrhea. This study aimed to clarify the effects of probiotic BBG9‐1 on the gastrointestinal symptoms of type 2 diabetes mellit...

Descripción completa

Detalles Bibliográficos
Autores principales: Hata, Shinnosuke, Nakajima, Hanako, Hashimoto, Yoshitaka, Miyoshi, Tomoki, Hosomi, Yukako, Okamura, Takuro, Majima, Saori, Nakanishi, Naoko, Senmaru, Takafumi, Osaka, Takafumi, Okada, Hiroshi, Ushigome, Emi, Hamaguchi, Masahide, Asano, Mai, Yamazaki, Masahiro, Fukui, Michiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902400/
https://www.ncbi.nlm.nih.gov/pubmed/34665938
http://dx.doi.org/10.1111/jdi.13698

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902400/
https://www.ncbi.nlm.nih.gov/pubmed/34665938
http://dx.doi.org/10.1111/jdi.13698

Ejemplares similares